Dermapharm Holding SE (DMP) — Long-term Investment Intensity
Dermapharm Holding SE (DMP) has a Long-term Investment Intensity of 6.8% as of September 2019. Long-term investments of €68.77 Million represent 6.8% of total assets of €1.02 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Dermapharm Holding SE asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Dermapharm Holding SE Long-term Investment Intensity (2014–2018)
This chart shows how Dermapharm Holding SE's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 6.8%, reflecting long-term investments of €68.77 Million against total assets of €1.02 Billion EUR. For the complete balance sheet picture, see Dermapharm Holding SE total assets.
Annual Long-term Investment Intensity for Dermapharm Holding SE (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for Dermapharm Holding SE from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Dermapharm Holding SE for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.7% | €4.85 Million | €704.58 Million | ▼ -0.2 pp |
| 2017 | 0.9% | €3.80 Million | €415.30 Million | ▼ -0.2 pp |
| 2016 | 1.1% | €3.56 Million | €311.70 Million | ▼ -4.3 pp |
| 2015 | 5.5% | €16.19 Million | €296.67 Million | ▲ +2.2 pp |
| 2014 | 3.3% | €10.87 Million | €330.60 Million | — |